[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Veterinary Oncology Market By Animal Type (Canine and Feline) By Therapy (Chemotherapy, Radiology, Surgery, Immunotherapy and Others) By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others) By Region, Industry Analysis and Forecast, 2020 - 2026

April 2020 | 209 pages | ID: G9CE0BD0173FEN
KBV Research

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Veterinary oncology Market size is expected to reach $369.2 Million by 2026, rising at a market growth of 13.2% CAGR during the forecast period. Cancer is one of the main causes of morbidity in veterinary patients and one of the most important surgical procedures undertaken by veterinarians is the surgical removal of tumors. The annual physical examination plays a crucial role in the diagnosis of neoplasia, either specifically through palpation or through paraneoplastic syndromes that can be detected on regular blood and urine analysis. The physical examination allows for the diagnosis of the involvement of cancers and the identification of concurrent conditions that can affect the treatment plan.
When a tumor is identified, the vet records its size, location, and gross appearance, and palpate regional lymph nodes. The suspicion of a metastatic neoplasm rises as the lymph nodes are swollen, solid, or immovable; however, normal lymph node palpation does not guarantee a lack of metastasis. Hence in most cases, some form of biopsy of the lymph node is recommended.
Intralesional, or debulking, surgery is incomplete resection of a tumor (within the pseudo capsule) with the residual gross disease. It is rarely an appropriate cure for neoplastic diseases, be it benign or malignant. This procedure leaves a tumor cell strain that is often too large, even with adjunctive therapies, such as radiation therapy and chemotherapy, to achieve a successful outcome.
Cancer is prevalent in dogs and in recent years, chemotherapy has progressed dramatically with canine oncology becoming a practice in many countries like the UK, Australia, and the US. However, there were no large-scale trials of the potential side effects of chemotherapeutic drugs in associated animals and very little debate on the ethics of using chemotherapy in these species. In general, the prognosis for animals suffering from malignant neoplasia (which can be conducive to chemotherapy) remains low, and the role of oncology in veterinary medicine can be debated.
Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
Strategies deployed in Veterinary Oncology Market
Nov-2019: Varian Medical Systems came into partnership with VCA Animal Hospitals. The partnership was announced as a part of the company's newly launched network of VCA Pet CancerCare Centers across North America for providing advanced pet cancer radiotherapy treatment at its specialty hospitals.
Aug-2019: Elanco Animal Health Inc. signed an agreement to acquire Bayer AG’s animal-health unit. The acquisition would strengthen Elanco's Animal Health business.
Aug-2019: Boehringer Ingelheim signed partnership agreement with The University of Texas MD Anderson Cancer Center. The partnership was focused on conducting collaborative research to rapidly advance therapies for various types of cancers, including gastrointestinal and lung cancers.
Jul-2019: Boehringer Ingelheim took over AMAL Therapeutics, a biotechnology company focused on cancer immunotherapy. The acquisition helped the company to become an innovator of novel cancer therapies, including immuno-oncology treatments.
Jul-2019: Elanco Animal Health completed the acquisition of Aratana Therapeutics. The acquisition complemented Elanco’s field presence and capitalized on new opportunities for Elanco pet therapy brands.
Jun-2019: Varian acquired Endocare and Alicon. The acquisition broadened its portfolio of multidisciplinary integrated cancer care solutions.
Jun-2018: Zoetis teamed up with Regeneron Pharmaceuticals. Through this collaboration, the companies aimed to research the use of Regeneron’s monoclonal antibody therapeutics in animals and discover new veterinary treatments.
Jul-2017: PetCure Oncology collaborated with Varian Medical Systems. The collaboration was aimed at bringing a different level of care to pets suffering from cancer. Under this collaboration, the Varian's software suite, including the RapidPlan and ARIA platforms were integrated across PetCure Oncology's national network of veterinary cancer care centers.
May-2017: Karyopharm Therapeutics signed a licensing agreement with Anivive Lifesciences, a biotech company focused on innovations in the veterinary drug and bioinformatics space. Following this agreement, the latter company got the exclusive rights from Karyopharm to research, develop, and commercialize verdinexor (KPT-335) for the treatment of cancer in companion animals.
May-2017: Varian Medical Systems launched the Halcyon system, a new device for cancer treatment. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT). This new treatment system has been designed for expanding the availability of high-quality cancer care and help save the lives of millions more cancer patients

Scope of the Study

Market Segmentation:

By Animal Type
  • Canine and
  • Feline
By Therapy
  • Chemotherapy
  • Radiology
  • Surgery
  • Immunotherapy and
  • Others
By Cancer Type
  • Lymphoma
  • Mast Cell Cancer
  • Mammary & Squamous Cell Cancer and
  • Others
By Geography
  • North America
    • US
    • Canada
        • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Companies Profiled
  • Boehringer Ingelheim International GmbH
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
      • Elanco Animal Health, Inc.
  • Zoetis, Inc.
  • Varian Medical Systems, Inc.
  • PetCure Oncology, LLC (Accelitech, LLC)
  • AB Science SA
  • Rhizen Pharmaceuticals S.A.
      • Nippon Zenyaku Kogyo Co., Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Veterinary Oncology Market, by Animal Type
  1.4.2 Global Veterinary Oncology Market, by Therapy
  1.4.3 Global Veterinary Oncology Market, by Cancer Type
  1.4.4 Global Veterinary Oncology Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. COMPETITION ANALYSIS - GLOBAL

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
  3.2.1 Partnerships, Collaborations and Agreements
  3.2.2 Product Launches and Product Expansions
  3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
  3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
  3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Sep – 2019, Nov) Leading Players

CHAPTER 4. GLOBAL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE

4.1 Global Canine Market by Region
4.2 Global Feline Market by Region

CHAPTER 5. GLOBAL VETERINARY ONCOLOGY MARKET BY THERAPY

5.1 Global Chemotherapy Market by Region
5.2 Global Radiology Market by Region
5.3 Global Surgery Market by Region
5.4 Global Immunotherapy Market by Region
5.5 Global Other Therapy Market by Region

CHAPTER 6. GLOBAL VETERINARY ONCOLOGY MARKET BY CANCER TYPE

6.1 Global Lymphoma Market by Region
6.2 Global Mast Cell Cancer Market by Region
6.3 Global Mammary & Squamous Cell Cancer Market by Region
6.4 Global Others Market by Region

CHAPTER 7. GLOBAL VETERINARY ONCOLOGY MARKET BY REGION

7.1 North America Veterinary Oncology Market
  7.1.1 North America Veterinary Oncology Market by Animal Type
    7.1.1.1 North America Canine Market by Country
    7.1.1.2 North America Feline Market by Country
  7.1.2 North America Veterinary Oncology Market by Therapy
    7.1.2.1 North America Chemotherapy Market by Country
    7.1.2.2 North America Radiology Market by Country
    7.1.2.3 North America Surgery Market by Country
    7.1.2.4 North America Immunotherapy Market by Country
    7.1.2.5 North America Other Therapy Market by Country
  7.1.3 North America Veterinary Oncology Market by Cancer Type
    7.1.3.1 North America Lymphoma Market by Country
    7.1.3.2 North America Mast Cell Cancer Market by Country
    7.1.3.3 North America Mammary & Squamous Cell Cancer Market by Country
    7.1.3.4 North America Others Market by Country
  7.1.4 North America Veterinary Oncology Market by Country
    7.1.4.1 US Veterinary Oncology Market
      7.1.4.1.1 US Veterinary Oncology Market by Animal Type
      7.1.4.1.2 US Veterinary Oncology Market by Therapy
      7.1.4.1.3 US Veterinary Oncology Market by Cancer Type
    7.1.4.2 Canada Veterinary Oncology Market
      7.1.4.2.1 Canada Veterinary Oncology Market by Animal Type
      7.1.4.2.2 Canada Veterinary Oncology Market by Therapy
      7.1.4.2.3 Canada Veterinary Oncology Market by Cancer Type
    7.1.4.3 Mexico Veterinary Oncology Market
      7.1.4.3.1 Mexico Veterinary Oncology Market by Animal Type
      7.1.4.3.2 Mexico Veterinary Oncology Market by Therapy
      7.1.4.3.3 Mexico Veterinary Oncology Market by Cancer Type
    7.1.4.4 Rest of North America Veterinary Oncology Market
      7.1.4.4.1 Rest of North America Veterinary Oncology Market by Animal Type
      7.1.4.4.2 Rest of North America Veterinary Oncology Market by Therapy
      7.1.4.4.3 Rest of North America Veterinary Oncology Market by Cancer Type
7.2 Europe Veterinary Oncology Market
  7.2.1 Europe Veterinary Oncology Market by Animal Type
    7.2.1.1 Europe Canine Market by Country
    7.2.1.2 Europe Feline Market by Country
  7.2.2 Europe Veterinary Oncology Market by Therapy
    7.2.2.1 Europe Chemotherapy Market by Country
    7.2.2.2 Europe Radiology Market by Country
    7.2.2.3 Europe Surgery Market by Country
    7.2.2.4 Europe Immunotherapy Market by Country
    7.2.2.5 Europe Other Therapy Market by Country
  7.2.3 Europe Veterinary Oncology Market by Cancer Type
    7.2.3.1 Europe Lymphoma Market by Country
    7.2.3.2 Europe Mast Cell Cancer Market by Country
    7.2.3.3 Europe Mammary & Squamous Cell Cancer Market by Country
    7.2.3.4 Europe Others Market by Country
  7.2.4 Europe Veterinary Oncology Market by Country
    7.2.4.1 Germany Veterinary Oncology Market
      7.2.4.1.1 Germany Veterinary Oncology Market by Animal Type
      7.2.4.1.2 Germany Veterinary Oncology Market by Therapy
      7.2.4.1.3 Germany Veterinary Oncology Market by Cancer Type
    7.2.4.2 UK Veterinary Oncology Market
      7.2.4.2.1 UK Veterinary Oncology Market by Animal Type
      7.2.4.2.2 UK Veterinary Oncology Market by Therapy
      7.2.4.2.3 UK Veterinary Oncology Market by Cancer Type
    7.2.4.3 France Veterinary Oncology Market
      7.2.4.3.1 France Veterinary Oncology Market by Animal Type
      7.2.4.3.2 France Veterinary Oncology Market by Therapy
      7.2.4.3.3 France Veterinary Oncology Market by Cancer Type
    7.2.4.4 Russia Veterinary Oncology Market
      7.2.4.4.1 Russia Veterinary Oncology Market by Animal Type
      7.2.4.4.2 Russia Veterinary Oncology Market by Therapy
      7.2.4.4.3 Russia Veterinary Oncology Market by Cancer Type
    7.2.4.5 Spain Veterinary Oncology Market
      7.2.4.5.1 Spain Veterinary Oncology Market by Animal Type
      7.2.4.5.2 Spain Veterinary Oncology Market by Therapy
      7.2.4.5.3 Spain Veterinary Oncology Market by Cancer Type
    7.2.4.6 Italy Veterinary Oncology Market
      7.2.4.6.1 Italy Veterinary Oncology Market by Animal Type
      7.2.4.6.2 Italy Veterinary Oncology Market by Therapy
      7.2.4.6.3 Italy Veterinary Oncology Market by Cancer Type
    7.2.4.7 Rest of Europe Veterinary Oncology Market
      7.2.4.7.1 Rest of Europe Veterinary Oncology Market by Animal Type
      7.2.4.7.2 Rest of Europe Veterinary Oncology Market by Therapy
      7.2.4.7.3 Rest of Europe Veterinary Oncology Market by Cancer Type
7.3 Asia Pacific Veterinary Oncology Market
  7.3.1 Asia Pacific Veterinary Oncology Market by Animal Type
    7.3.1.1 Asia Pacific Canine Market by Country
    7.3.1.2 Asia Pacific Feline Market by Country
  7.3.2 Asia Pacific Veterinary Oncology Market by Therapy
    7.3.2.1 Asia Pacific Chemotherapy Market by Country
    7.3.2.2 Asia Pacific Radiology Market by Country
    7.3.2.3 Asia Pacific Surgery Market by Country
    7.3.2.4 Asia Pacific Immunotherapy Market by Country
    7.3.2.5 Asia Pacific Other Therapy Market by Country
  7.3.3 Asia Pacific Veterinary Oncology Market by Cancer Type
    7.3.3.1 Asia Pacific Lymphoma Market by Country
    7.3.3.2 Asia Pacific Mast Cell Cancer Market by Country
    7.3.3.3 Asia Pacific Mammary & Squamous Cell Cancer Market by Country
    7.3.3.4 Asia Pacific Others Market by Country
  7.3.4 Asia Pacific Veterinary Oncology Market by Country
    7.3.4.1 China Veterinary Oncology Market
      7.3.4.1.1 China Veterinary Oncology Market by Animal Type
      7.3.4.1.2 China Veterinary Oncology Market by Therapy
      7.3.4.1.3 China Veterinary Oncology Market by Cancer Type
    7.3.4.2 Japan Veterinary Oncology Market
      7.3.4.2.1 Japan Veterinary Oncology Market by Animal Type
      7.3.4.2.2 Japan Veterinary Oncology Market by Therapy
      7.3.4.2.3 Japan Veterinary Oncology Market by Cancer Type
    7.3.4.3 India Veterinary Oncology Market
      7.3.4.3.1 India Veterinary Oncology Market by Animal Type
      7.3.4.3.2 India Veterinary Oncology Market by Therapy
      7.3.4.3.3 India Veterinary Oncology Market by Cancer Type
    7.3.4.4 South Korea Veterinary Oncology Market
      7.3.4.4.1 South Korea Veterinary Oncology Market by Animal Type
      7.3.4.4.2 South Korea Veterinary Oncology Market by Therapy
      7.3.4.4.3 South Korea Veterinary Oncology Market by Cancer Type
    7.3.4.5 Singapore Veterinary Oncology Market
      7.3.4.5.1 Singapore Veterinary Oncology Market by Animal Type
      7.3.4.5.2 Singapore Veterinary Oncology Market by Therapy
      7.3.4.5.3 Singapore Veterinary Oncology Market by Cancer Type
    7.3.4.6 Malaysia Veterinary Oncology Market
      7.3.4.6.1 Malaysia Veterinary Oncology Market by Animal Type
      7.3.4.6.2 Malaysia Veterinary Oncology Market by Therapy
      7.3.4.6.3 Malaysia Veterinary Oncology Market by Cancer Type
    7.3.4.7 Rest of Asia Pacific Veterinary Oncology Market
      7.3.4.7.1 Rest of Asia Pacific Veterinary Oncology Market by Animal Type
      7.3.4.7.2 Rest of Asia Pacific Veterinary Oncology Market by Therapy
      7.3.4.7.3 Rest of Asia Pacific Veterinary Oncology Market by Cancer Type
7.4 LAMEA Veterinary Oncology Market
  7.4.1 LAMEA Veterinary Oncology Market by Animal Type
    7.4.1.1 LAMEA Canine Market by Country
    7.4.1.2 LAMEA Feline Market by Country
  7.4.2 LAMEA Veterinary Oncology Market by Therapy
    7.4.2.1 LAMEA Chemotherapy Market by Country
    7.4.2.2 LAMEA Radiology Market by Country
    7.4.2.3 LAMEA Surgery Market by Country
    7.4.2.4 LAMEA Immunotherapy Market by Country
    7.4.2.5 LAMEA Other Therapy Market by Country
  7.4.3 LAMEA Veterinary Oncology Market by Cancer Type
    7.4.3.1 LAMEA Lymphoma Market by Country
    7.4.3.2 LAMEA Mast Cell Cancer Market by Country
    7.4.3.3 LAMEA Mammary & Squamous Cell Cancer Market by Country
    7.4.3.4 LAMEA Others Market by Country
  7.4.4 LAMEA Veterinary Oncology Market by Country
    7.4.4.1 Brazil Veterinary Oncology Market
      7.4.4.1.1 Brazil Veterinary Oncology Market by Animal Type
      7.4.4.1.2 Brazil Veterinary Oncology Market by Therapy
      7.4.4.1.3 Brazil Veterinary Oncology Market by Cancer Type
    7.4.4.2 Argentina Veterinary Oncology Market
      7.4.4.2.1 Argentina Veterinary Oncology Market by Animal Type
      7.4.4.2.2 Argentina Veterinary Oncology Market by Therapy
      7.4.4.2.3 Argentina Veterinary Oncology Market by Cancer Type
    7.4.4.3 UAE Veterinary Oncology Market
      7.4.4.3.1 UAE Veterinary Oncology Market by Animal Type
      7.4.4.3.2 UAE Veterinary Oncology Market by Therapy
      7.4.4.3.3 UAE Veterinary Oncology Market by Cancer Type
    7.4.4.4 Saudi Arabia Veterinary Oncology Market
      7.4.4.4.1 Saudi Arabia Veterinary Oncology Market by Animal Type
      7.4.4.4.2 Saudi Arabia Veterinary Oncology Market by Therapy
      7.4.4.4.3 Saudi Arabia Veterinary Oncology Market by Cancer Type
    7.4.4.5 South Africa Veterinary Oncology Market
      7.4.4.5.1 South Africa Veterinary Oncology Market by Animal Type
      7.4.4.5.2 South Africa Veterinary Oncology Market by Therapy
      7.4.4.5.3 South Africa Veterinary Oncology Market by Cancer Type
    7.4.4.6 Nigeria Veterinary Oncology Market
      7.4.4.6.1 Nigeria Veterinary Oncology Market by Animal Type
      7.4.4.6.2 Nigeria Veterinary Oncology Market by Therapy
      7.4.4.6.3 Nigeria Veterinary Oncology Market by Cancer Type
    7.4.4.7 Rest of LAMEA Veterinary Oncology Market
      7.4.4.7.1 Rest of LAMEA Veterinary Oncology Market by Animal Type
      7.4.4.7.2 Rest of LAMEA Veterinary Oncology Market by Therapy
      7.4.4.7.3 Rest of LAMEA Veterinary Oncology Market by Cancer Type

CHAPTER 8. COMPANY PROFILES

8.1 Boehringer Ingelheim International GmbH
  8.1.1 Company Overview
  8.1.2 Financial Analysis
  8.1.3 Segmental and Regional Analysis
  8.1.4 Research & Development Expense
  8.1.5 Recent strategies and developments:
    8.1.5.1 Partnerships, Collaborations, and Agreements:
    8.1.5.2 Acquisition and Mergers:
8.2 Karyopharm Therapeutics, Inc.
  8.2.1 Company overview
  8.2.2 Financial Analysis
  8.2.3 Research & Development Expenses
  8.2.4 Recent strategies and developments:
    8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Regeneus Ltd.
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Research & Development Expense
8.4 Elanco Animal Health, Inc.
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Regional Analysis
  8.4.4 Research & Development Expenses
  8.4.5 Recent strategies and developments:
    8.4.5.1 Acquisition and Mergers:
8.5 Zoetis, Inc.
  8.5.1 Company Overview
  8.5.2 Financial Analysis
  8.5.3 Regional Analysis
  8.5.4 Research & Development Expenses
  8.5.5 Recent strategies and developments:
    8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Varian Medical Systems, Inc.
  8.6.1 Company Overview
  8.6.2 Financial Analysis
  8.6.3 Segmental and Regional Analysis
  8.6.4 Research & Development Expense
  8.6.5 Recent strategies and developments:
    8.6.5.1 Acquisition and Mergers:
    8.6.5.2 Partnerships, Collaborations, and Agreements:
    8.6.5.3 Product Launches and Product Expansions:
8.7 PetCure Oncology, LLC (Accelitech, LLC)
  8.7.1 Company Overview
  8.7.2 Recent strategies and developments:
    8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 AB Science SA
  8.8.1 Company Overview
  8.8.2 Financial Analysis
  8.8.3 Research & Development Expense
8.9 Rhizen Pharmaceuticals S.A.
  8.9.1 Company Overview
8.1 Nippon Zenyaku Kogyo Co., Ltd.
  8.10.1 Company Overview

LIST OF TABLES

TABLE 1 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– VETERINARY ONCOLOGY MARKET
TABLE 2 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– VETERINARY ONCOLOGY MARKET
TABLE 3 MERGERS & ACQUISITIONS – VETERINARY ONCOLOGY MARKET
TABLE 4 GLOBAL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 5 GLOBAL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 6 GLOBAL CANINE MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 7 GLOBAL CANINE MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 8 GLOBAL FELINE MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 9 GLOBAL FELINE MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 10 GLOBAL VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 11 GLOBAL VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 12 GLOBAL CHEMOTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 13 GLOBAL CHEMOTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 14 GLOBAL RADIOLOGY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 15 GLOBAL RADIOLOGY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 16 GLOBAL SURGERY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 17 GLOBAL SURGERY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 18 GLOBAL IMMUNOTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 19 GLOBAL IMMUNOTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 20 GLOBAL OTHER THERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 21 GLOBAL OTHER THERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 22 GLOBAL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 23 GLOBAL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 24 GLOBAL LYMPHOMA MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 25 GLOBAL LYMPHOMA MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 26 GLOBAL MAST CELL CANCER MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 27 GLOBAL MAST CELL CANCER MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 28 GLOBAL MAMMARY & SQUAMOUS CELL CANCER MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 29 GLOBAL MAMMARY & SQUAMOUS CELL CANCER MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 30 GLOBAL OTHERS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 31 GLOBAL OTHERS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 32 GLOBAL VETERINARY ONCOLOGY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 33 GLOBAL VETERINARY ONCOLOGY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 34 NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 35 NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 36 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 37 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 38 NORTH AMERICA CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 39 NORTH AMERICA CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 40 NORTH AMERICA FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 41 NORTH AMERICA FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 42 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 43 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 44 NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 45 NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 46 NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 47 NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 48 NORTH AMERICA SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 49 NORTH AMERICA SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 50 NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 51 NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 52 NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 53 NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 54 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 55 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 56 NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 57 NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 58 NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 59 NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 60 NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 61 NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 62 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 63 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 64 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 65 NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 66 US VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 67 US VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 68 US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 69 US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 70 US VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 71 US VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 72 US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 73 US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 74 CANADA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 75 CANADA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 76 CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 77 CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 78 CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 79 CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 80 CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 81 CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 82 MEXICO VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 83 MEXICO VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 84 MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 85 MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 86 MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 87 MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 88 MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 89 MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 90 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 91 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 92 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 93 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 94 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 95 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 96 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 97 REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 98 EUROPE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 99 EUROPE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 100 EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 101 EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 102 EUROPE CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 103 EUROPE CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 104 EUROPE FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 105 EUROPE FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 106 EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 107 EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 108 EUROPE CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 109 EUROPE CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 110 EUROPE RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 111 EUROPE RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 112 EUROPE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 113 EUROPE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 114 EUROPE IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 115 EUROPE IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 116 EUROPE OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 117 EUROPE OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 118 EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 119 EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 120 EUROPE LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 121 EUROPE LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 122 EUROPE MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 123 EUROPE MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 124 EUROPE MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 125 EUROPE MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 126 EUROPE OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 127 EUROPE OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 128 EUROPE VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 129 EUROPE VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 130 GERMANY VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 131 GERMANY VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 132 GERMANY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 133 GERMANY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 134 GERMANY VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 135 GERMANY VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 136 GERMANY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 137 GERMANY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 138 UK VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 139 UK VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 140 UK VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 141 UK VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 142 UK VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 143 UK VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 144 UK VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 145 UK VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 146 FRANCE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 147 FRANCE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 148 FRANCE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 149 FRANCE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 150 FRANCE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 151 FRANCE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 152 FRANCE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 153 RUSSIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 154 RUSSIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 155 RUSSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 156 RUSSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 157 RUSSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 158 RUSSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 159 RUSSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 160 RUSSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 161 SPAIN VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 162 SPAIN VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 163 SPAIN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 164 SPAIN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 165 SPAIN VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 166 SPAIN VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 167 SPAIN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 168 SPAIN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 169 ITALY VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 170 ITALY VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 171 ITALY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 172 ITALY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 173 ITALY VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 174 ITALY VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 175 ITALY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 176 ITALY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 177 REST OF EUROPE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 178 REST OF EUROPE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 179 REST OF EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 180 REST OF EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 181 REST OF EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 182 REST OF EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 183 REST OF EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 184 REST OF EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 185 ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 186 ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 187 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 188 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 189 ASIA PACIFIC CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 190 ASIA PACIFIC CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 191 ASIA PACIFIC FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 192 ASIA PACIFIC FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 193 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 194 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 195 ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 196 ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 197 ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 198 ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 199 ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 200 ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 201 ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 202 ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 203 ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 204 ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 205 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 206 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 207 ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 208 ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 209 ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 210 ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 211 ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 212 ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 213 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 214 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 215 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 216 ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 217 CHINA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 218 CHINA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 219 CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 220 CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 221 CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 222 CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 223 CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 224 CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 225 JAPAN VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 226 JAPAN VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 227 JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 228 JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 229 JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 230 JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 231 JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 232 JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 233 INDIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 234 INDIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 235 INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 236 INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 237 INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 238 INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 239 INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 240 INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 241 SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 242 SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 243 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 244 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 245 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 246 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 247 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 248 SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 249 SINGAPORE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 250 SINGAPORE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 251 SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 252 SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 253 SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 254 SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 255 SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 256 SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 257 MALAYSIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 258 MALAYSIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 259 MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 260 MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 261 MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 262 MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 263 MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 264 MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 265 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 266 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 267 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 268 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 269 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 270 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 271 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 272 REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 273 LAMEA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 274 LAMEA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 275 LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 276 LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 277 LAMEA CANINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 278 LAMEA CANINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 279 LAMEA FELINE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 280 LAMEA FELINE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 281 LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 282 LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 283 LAMEA CHEMOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 284 LAMEA CHEMOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 285 LAMEA RADIOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 286 LAMEA RADIOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 287 LAMEA SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 288 LAMEA SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 289 LAMEA IMMUNOTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 290 LAMEA IMMUNOTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 291 LAMEA OTHER THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 292 LAMEA OTHER THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 293 LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 294 LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 295 LAMEA LYMPHOMA MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 296 LAMEA LYMPHOMA MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 297 LAMEA MAST CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 298 LAMEA MAST CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 299 LAMEA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 300 LAMEA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 301 LAMEA OTHERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 302 LAMEA OTHERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 303 LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 304 LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 305 BRAZIL VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 306 BRAZIL VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 307 BRAZIL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 308 BRAZIL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 309 BRAZIL VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 310 BRAZIL VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 311 BRAZIL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 312 BRAZIL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 313 ARGENTINA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 314 ARGENTINA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 315 ARGENTINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 316 ARGENTINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 317 ARGENTINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 318 ARGENTINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 319 ARGENTINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 320 ARGENTINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 321 UAE VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 322 UAE VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 323 UAE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 324 UAE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 325 UAE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 326 UAE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 327 UAE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 328 UAE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 329 SAUDI ARABIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 330 SAUDI ARABIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 331 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 332 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 333 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 334 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 335 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 336 SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 337 SOUTH AFRICA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 338 SOUTH AFRICA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 339 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 340 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 341 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 342 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 343 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 344 SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 345 NIGERIA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 346 NIGERIA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 347 NIGERIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 348 NIGERIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 349 NIGERIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 350 NIGERIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 351 NIGERIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 352 NIGERIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 353 REST OF LAMEA VETERINARY ONCOLOGY MARKET, 2016 - 2019, USD MILLION
TABLE 354 REST OF LAMEA VETERINARY ONCOLOGY MARKET, 2020 - 2026, USD MILLION
TABLE 355 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016 - 2019, USD MILLION
TABLE 356 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020 - 2026, USD MILLION
TABLE 357 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016 - 2019, USD MILLION
TABLE 358 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020 - 2026, USD MILLION
TABLE 359 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016 - 2019, USD MILLION
TABLE 360 REST OF LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020 - 2026, USD MILLION
TABLE 361 KEY INFORMATION – BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 362 KEY INFORMATION – KARYOPHARM THERAPEUTICS, INC.
TABLE 363 KEY INFORMATION – REGENEUS LTD.
TABLE 364 KEY INFORMATION – ELANCO ANIMAL HEALTH, INC.
TABLE 365 KEY INFORMATION – ZOETIS, INC.
TABLE 366 KEY INFORMATION –-VARIAN MEDICAL SYSTEMS, INC.
TABLE 367 KEY INFORMATION – PETCURE ONCOLOGY, LLC
TABLE 368 KEY INFORMATION – AB SCIENCE SA
TABLE 369 KEY INFORMATION – RHIZEN PHARMACEUTICALS S.A.
TABLE 370 KEY INFORMATION – NIPPON ZENYAKU KOGYO CO., LTD.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, SEP – 2019, NOV) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.


More Publications